SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001437749-17-005818
Filing Date
2017-04-03
Accepted
2017-03-31 20:59:20
Documents
1
Period of Report
2016-12-31
Effectiveness Date
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM NT 10-K atrn20170330_nt10k.htm NT 10-K 29160
  Complete submission text file 0001437749-17-005818.txt   30495
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-51353 | Film No.: 17732080
SIC: 7389 Services-Business Services, NEC